Paishi Tonglin Koufuye (排石通淋口服液)排石通淋口服液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

金钱草是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:丹参等Danshen Deng、白芍peony、茯苓Fu Ling、茵陈Yin Chen、虎杖Hu Zhang。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:丹参等-2573905a成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 排石通淋口服液) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 丹参等Danshen Deng, 白芍peony, 茯苓Fu Ling, 茵陈Yin Chen, 虎杖Hu Zhang.

Explore other medicines containing the same ingredient: 丹参等 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 排石通淋口服液Recorded Chinese name: 排石通淋口服液
  • 剂型Dosage form: 口服液剂Oral liquid
  • 规格Specification: 每支装10ml10 mL per unit

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 黑龙江省林宝药业有限责任公司Chinese legal name: 黑龙江省林宝药业有限责任公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字B20030003

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字B20030003

Manufacturer

Chinese legal name: 黑龙江省林宝药业有限责任公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字B20030003

生产企业

黑龙江省林宝药业有限责任公司(国产)

适应症

清热利胆,通淋排石。用于尿石症,胆石症属湿热蕴结证者,可改善小便涩痛,小腹疼痛,尿中带血,或有右胁疼痛,发热黄疸,舌苔黄腻等症状。

用法用量

口服,一日4次,首次2支,后每次1支;或遵医嘱

不良反应

少数病倒出现以度腹痛症状。

禁忌

孕妇或妇女哺乳期禁用。

注意事项

1.结石梗阻严重者慎用;
2.请在医生指导下使用。

贮藏

密封,置阴凉处。

规格

每支装10ml

证据Evidence

  • 批准文号: 国药准字B20030003
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.